Computer-assisted design of dual-target anti-HIV-1 compounds

Anti-HIV compounds comprise inhibitors of some different biological targets, like HIV protease, integrase and reverse transcriptase enzymes, and entry and fusion proteins. These drugs are usually administered in drug cocktails (AIDS cocktails); the use of a single multi-target anti-HIV-1 compound ag...

Full description

Saved in:
Bibliographic Details
Published in:Medicinal chemistry research 2014-03, Vol.23 (3), p.1548-1558
Main Authors: Guimarães, Maria C., Silva, Daniel G., da Mota, Estella G., da Cunha, Elaine F. F., Freitas, Matheus P.
Format: Article
Language:English
Subjects:
Biochemistry
Biomedical and Life Sciences
Biomedicine
Cell Biology
Original Research
Pharmacology/Toxicology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anti-HIV compounds comprise inhibitors of some different biological targets, like HIV protease, integrase and reverse transcriptase enzymes, and entry and fusion proteins. These drugs are usually administered in drug cocktails (AIDS cocktails); the use of a single multi-target anti-HIV-1 compound against AIDS would avoid a more exhaustive therapeutic treatment. The QSAR modeling of reverse transcriptase inhibitors and anti-HIV-1 compounds in general is reported and, given some substructural similarity between the compounds of these two classes, novel compounds with possible double action against HIV-1 were proposed and their bioactivities estimated using the QSAR model. Docking studies were also developed to validate the QSAR predictions, as well as to understand the mode of interaction of the proposed compounds and to compute the docking scores of some derivatives (not predictable using the QSAR model) in the active site of HIV reverse transcriptase.
ISSN:1054-2523
1554-8120
DOI:10.1007/s00044-013-0765-3